Cartesian Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25; Deep and durable responses maintained over 12 months in ...
The Manila Times21m
Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
Investors are encouraged to read the Company's Annual Report on Form 10-K when it is filed with the Securities and Exchange ...